BankInvest invests in Ark Therapeutics

BankInvest, the Danish asset management house, has invested in Ark Therapeutics, the Anglo-Finnish biotechnology company which raised a total of £14.5m (€23m) in its third round of fundraising.

BankInvest led the financing round alongside investors that include Merlin Biosciences and Nomura International.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump